Markers of Airway Remodeling in Bronchopulmonary Diseases

Article Sidebar

PDF (Русский)
Published: Dec 17, 2014
DOI: https://doi.org/10.22141/2224-0551.7.58.2014.75838
Keywords:
airway remodeling, markers.

Main Article Content

O.Ye. Chernyshova
Donetsk National Medical University named after M. Horkyi, Donetsk

Abstract

The article presents information about markers of airway remodeling in bronchopulmonary diseases. There is described the influence of matrix metalloproteinases, tissue inhibitor of matrix metalloproteinase, transforming growth factor, collagen autoantibodies III type, endothelin-1 on the processes of morphological airway reconstruction as smooth muscle hypertrophy, enhanced neovascularization, epithelial cell hyperplasia, collagen deposition, compaction of the basal membrane, observed in bronchial asthma.

Article Details

How to Cite
Chernyshova, O. “Markers of Airway Remodeling in Bronchopulmonary Diseases”. CHILD`S HEALTH, no. 7.58, Dec. 2014, pp. 80-83, doi:10.22141/2224-0551.7.58.2014.75838.
Issue
No. 7.58 (2014)
Section
Theoretical Medicine
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Our edition uses the copyright terms of Creative Commons for open access journals.

Authors, who are published in this journal, agree with the following terms:

  1. The authors retain rights for authorship of their article and grant to the edition the right of first publication of the article on a Creative Commons Attribution 4.0 International License, which allows others to freely distribute the published article, with the obligatory reference to the authors of original works and original publication in this journal.
  2. Directing  the article for the publication to the editorial board (publisher), the author agrees with transmitting of rights for the protection and using the article, including parts of the article, which are protected by the copyrights, such as the author’s photo, pictures, charts, tables, etc., including the reproduction in the media and the Internet; for distributing; for the translation of the manuscript in all languages; for export and import of the publications copies of the writers’ article to spread, bringing to the general information.
  3. The rights mentioned above authors transfer to the edition (publisher) for the unlimited period of validity and on the territory of all countries of the world.
  4. The authors guarantee that they have exclusive rights for using of the article, which they have sent to the edition (publisher). The edition (the publisher) is not responsible for the violation of given guarantees by the authors to the third parties.
  5. The authors have the right to conclude separate supplement agreements that relate to non-exclusive distribution of their article in the form in which it had been published in the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
  6. The policy of the journal permits and encourages the publication of the article in the Internet (in institutional repository or on a personal website) by the authors, because it contributes to productive scientific discussion and a positive effect on efficiency and dynamics of the citation of the article.
  7. The rights to the article are deemed transferred by the authors to the edition (the publisher) since the moment of the publication of the article in the printed or electronic version of journal. 

References

Литвинець Л.Я. Концепція динаміки змін показників імунного статусу у дітей з бронхіальною астмою залежно від ступеня контрольованості недуги // Перинатология и педиатрия. — 2011. — № 2 (46). — С. 104-406.

Бронхиальная астма: современные концепции диагностики и лечения. Научно-информационный материал. — М., 2011. — 127 с.

Fixman E.D., Stewart A., Martin J.G. Basic mechanisms of development of airway structural changes in asthma // Eur. Respir. J. — 2007. — Vol. 29. — P. 379-389.

Фисенко В., Чичкова Н. Ремоделирование при бронхиальной астме: принципы формирования и возможности фармакологического воздействия // Врач. — 2006. — № 12. — С. 14-20.

Ненартович И.А., Жерносек В.Ф. Ремоделирование бронхов при бронхиальной астме и возможности его коррекции // Рецепт. — 2010. — № 3 (71). — С. 77-89.

Fredberg J.J. Bronchospasm and its biophysical basis in airway smooth muscle // Resp. Res. — 2004. — Vol. 5. — P. 2-17.

Антипкін Ю.Г., Надточій Т.Г. Сучасні погляди на етіопатогенез, клінінко-діагностичні та лікувально-профілактичні особливості перебігу запального процессу при неспецифічних захворюваннях органів дихання у дітей (огляд літератури) // Перинаталогия и педиатрия. — 2011. — № 1 (45). — С. 19-23.

Ласиця О.Л., Охотнікова О.М. Діагностика, лікування і профілактика бронхіальної астми у дітей. — К., 2006. — С. 4-24.

Христич Т.Н. К вопросу о патогенезе сочетанных заболеваний органов пищеварения и бронхолегочной системы // Український терапевтичний журнал. — 2006. — № 2. — С. 88-91.

Gualano R.C., Vlahos R., Anderson G.P. What is the contribution of respiratory viruses and lung proteases to airway remodeling in asthma and chronic obstructive pulmonary disease // Pulm. Pharmacol. Ther. — 2006. — Vol. 19. — P. 18-23.

Kelly E.A., Jarjour N.N. Role of matrix metalloproteinases in asthma // Curr. Opin. Pulm. Med. — 2003. — Vol. 9. — P. 28-33.

Kips J.C., Pauwels R.A. Airway wall remodeling: does it occur and what does it mean? // Clin. Exp. Allergy. — 1999. — Vol. 29. — P. 1457-1466.

Atkinson J., Senior R.M. Matrix metalloproteinase-9 in lung remodeling // Am. J. Respir. Cell Mol. Biol. — 2003. — Vol. 28. — P. 12-24.

Приходько А.Г., Перельман Ю.М., Колосов В.П. Гиперреактивность дыхательных путей. — Владивосток: Дальнаука, 2011. — 204 с.

Kariyawasam H.H., Robinson D.S. Airway remodeling in asthma: models and supermodels // Clin. Exp. Allergy. — 2005. — Vol. 35. — P. 117-121.

Ильченко С.И. Диагностическая значимость уровня сывороточного трансформирующего фактора роста у детей с рецидивирующими и хроническими бронхитами // Клиническая педиатрия. — 2008. — № 6 (15). — С. 15-17.

Postma D.S., Kerstjens H.A.M. Characteristics of airway hyperresponsiveness in asthma and chronic obstructive pulmonary disease // Am. J. Respir. Crit. Care Med. — 1998. — Vol. 158, № 5. — P. 187-192.

Bronchial CD8 cell infiltrate and lung function decline in asthma / E.L. van Rensen [et al.] // Am. J. Respir. Crit. Care Med. — 2005. — Vol. 172. — P. 837-841.

Barnes P.J. Mediators of chronic obstructive pulmonary di­sease // Pharmacol. Rev. — 2004. — Vol. 56. — P. 515-548.

Ten Hacken N.H.T., Postma D.S., Timens W. Airway remo­deling and long-term decline in lung function in asthma // Curr. Opin. Pulm. Med. — 2003. — Vol. 9. — P. 9-14.

Boxall C., Holgate S.T., Davies D.E. The contribution of transforming growth factor-b and epidermal growth factor signaling to airway remodeling in chronic asthma // Eur. Respir. J. — 2006. — Vol. 27. — P. 208-229.

Глобальная стратегия лечения и профилактики бронхиальной астмы. Пересмотр 2006 г. / Под ред. Чучалина А.Г. — М.: Атмосфера, 2007. — 104 с.

Стройкова Т.Р. Клинико-диагностическое значение аутоантител к коллагену III типа при бронхолегочных заболеваниях у детей: Автореф. дис… канд. мед. наук. — Астрахань, 2009. — 20 с.

Баранов А.А., Балаболкин И.И, Геппе Н.А. Бронхиальная астма у детей: диагностика, лечение и профилактика. — М.: Медицина, 2004. — 48 с.

Княжеская Н.П. Современные аспекты диагностики бронхиальной астмы // Врач. — 2004. — № 7. — С. 23-29.

The course of persistent airflow limitation in subjects with and without asthma / S. Guerra [et al.] // Respir. Med. — 2008. — Vol. 102. — P. 1473-1482.

Most read articles by the same author(s)

1 2 3 > >>